Igor Proscurshim

Dr. Igor Proscurshim, a seasoned professional with a background in surgery and drug development, has dedicated over a decade to clinical research, specializing in colorectal cancer and drug development.

Throughout his career, Dr. Proscurshim has held various key roles at reputable organizations such as Recepta Biopharma, Agenus, and currently serves as the Senior Medical Director at Takeda Oncology, overseeing clinical leadership for Immuno-oncology assets in solid tumors and hematologic malignancies.

His journey began in surgery and later evolved into the realm of drug development, driven by a passion to deliver life-saving medications to patients. He has amassed experience in diverse areas including building research for drug candidate selection, crafting drug development plans, managing candidate drug portfolios, and engaging in both in-licensing and out-licensing of intellectual property.

Having transitioned from being a Chief Scientific Officer at a small Biotech startup to roles like Director of Business Development and Medical Director at prominent companies, Dr. Proscurshim brings a wealth of expertise in clinical development and strategic partnerships.

Dr. Proscurshim's educational background includes General Surgery Residency from the University of São Paulo School of Medicine, an MD in Medicine from Universidade de São Paulo, and a BS in Biology from Baylor University.

His professional journey showcases a seamless blend of surgical skills, logical thinking, and a relentless drive to positively impact the lives of countless patients through innovative drug development initiatives.